A “range of strategic alternatives”, including breaking up the company or merging with another firm, is on the table for Aceto as the company grapples with “persistent adverse conditions in the generics market”. As part of the “immediate and proactive steps” being taken by the firm’s board, a new interim chief financial officer, Rebecca Roof, has been appointed to replace Edward Borkowski.
Emphasising that financial guidance issued at the start of February “should no longer be relied upon”, the firm said it...






